Compositions of peptide inhibitors of Interleukin-23 receptor
US11939361B2 · kind B2 · utility
0Cited by
44References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 19, 2021 |
| Grant date | Mar 26, 2024 |
| Priority date | — |
| Expiry date | Nov 19, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions of peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salt or solvate forms thereof, corresponding pharmaceutical compositions, methods and/or uses for treatment of autoimmune inflammation and related diseases and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.